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GUVEpsilon-toxin (ETX) is a powerful toxin produced by some strains of Clostridium perfringens (classiﬁed as types B
and D) that is responsible for enterotoxemia in animals. ETX forms pores through the plasma membrane of eu-
karyotic cells, consisting of a β-barrel of 14 amphipathic β-strands. ETX shows a high speciﬁcity for certain cell
lines, of whichMadin–Darby canine kidney (MDCK) is the ﬁrst sensitive cell line identiﬁed and themost studied
one. The aim of this studywas to establish the role of lipids in the toxicity caused by ETX and the correlation of its
activity inmodel and biologicalmembranes. InMDCK cells, using cell counting and confocalmicroscopy,we have
observed that the toxin causes cell death mediated by toxin binding to plasma membrane. Moreover, ETX binds
and permeabilizes themembranes of giant plasmamembrane vesicles (GPMV). However, little effect is observed
on protein-free vesicles. The data suggest the essential role of a protein receptor for the toxin in cell membranes.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Epsilon-toxin (ETX) is a pore-forming protein produced by
toxinotypes B and D of Clostridium perfringens [1]. This aerotolerant,
anaerobic, widespread bacteria is responsible for a certain number of
diseases caused by different toxins. Among them, ETX is one of the
most potent toxins known, for this reason, it is considered a potential
biological weapon and is classiﬁed as a category B biological agent,
although very few natural diseases have been reported in humans [2,
3]. However, in animals, it is responsible for enterotoxemia, especially
in sheep causing an important damage to the world economy, since
these animals occupy a premier place in the livestock [4]. ETX belongs
to the heptameric β-pore-forming toxin family that includes aerolysin
and C. septicum alpha-toxin. Despite low sequence identity (14%), the
general structure of the toxin is related to the pore-forming toxin
aerolysin produced by Aeromonas species, although epsilon-toxin is
much more potent by 100-fold than aerolysin. These toxins are charac-
terized by the formation of a pore through the plasmamembrane of eu-
karyotic cells, consisting of a β-barrel of 14 amphipatic β-strands [5].
ETX is synthesized during exponential growth of C. perfringens as a
protoxin with a very low activity. Epsilon-protoxin (EPTX) is composed
of 296 amino acids (32.9 kDa) and is activated by proteolytic cleavage
by different proteases depending on the site of activation [6]. Trypsin
cleaves 13 amino acids from the N-terminal and 22 from the C-
terminal end, the result is a protein with a low toxicity in mice with
an LD50 of 320 ng·kg−1. Themost active form of epsilon-toxin is obtain-
ed by a combination of trypsin and chymotrypsin that cleave 13 aminoacids from the N-terminal and 29 from the C-terminal domains,
obtaining a shorter protein and an LD50 of 50–65 ng·kg−1. Moreover,
lambda-protease cuts in 10 residues from the N-terminal and 29
from the C-terminal domain giving rise to an activity with LD50 =
110 ng·kg−1 [6].
The effect of ETX on membrane models is not clear. It has been de-
scribed that the toxin is able to cause carboxyﬂuorescein leakage in
multilamellar vesicles (MLV) and to insert in monolayers in a manner
dependent on the toxin doses and the ﬂuidity of the lipid [7]. Moreover,
also the ability of ETX to permeabilize “black lipid” bilayers was studied,
with the conclusion that the toxin causes permeability preferentially to
anions in bilayers composed of different lipids [8]. Regarding the cellular
effects, ETX shows a high speciﬁcity for a few cell lines, e.g., Madin–
Darby canine kidney (MDCK), the ﬁrst sensitive cell line identiﬁed and
the most studied one, G-402 (human renal leiomyoblastoma cell line)
or mpkCCDc14 (Mouse Cortical Collecting Duct cell line). Some cells
susceptible of ETX attack in vivo are not sensitive if isolated and grown
in vitro; indeed, kidney cell lines from ETX-susceptible animal species
like lamb and cattle are resistant to the toxin, suggesting that an ETX
receptor in primary cells is lost in cultured cell lines [9]. However, the
canine cells used in the present study remain ETX-sensitive in second-
ary cultures. The mechanism proposed for ETX cytotoxicity follows dif-
ferent steps. In the ﬁrst step, the toxin binds a speciﬁc receptor localized
in the plasma membrane. The toxin appears to be localized as a
heptamer in detergent-resistant domains (DRM) isolated from MDCK
cells, so that a receptor could be localized in cholesterol-rich domains
[10]. The second step of cytotoxicity consists of the heptamerization of
the toxin and formation of the pore. This step is prevented by depletion
of cholesterol by methyl-β-cyclodextrin that inactivates the binding of
ETX to plasma membrane and the pore formation [11]. Different
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ature, in the ﬁrst phase of intoxication a marked swelling is observed,
followed by vacuolization, mitochondria disappearance, blebbing and
membrane disruption [12].
In the presentwork, we have studied and compared the effect of ETX
in membrane models and cells, to improve our understanding of the
role of proteins and lipids in the interaction of ETX with plasma mem-
brane. ETX shows no effect on vesicles of pure lipid composition, but it
partitions into the membrane of giant plasma membrane vesicles
formed by blebbing of MDCK cells, suggesting that a protein receptor
is involved in the cytolytic process.2. Materials and methods
2.1. Materials
Egg sphingomyelin (SM), cholesterol (Ch), diacylglycerol-
3-ethyl phosphocholine (ethyl PC), 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC), phosphatidylinositol-
4-phosphate (PiP), 1,2-dioleoyl-sn-glycero-3-phosphocholine
(DOPC) dipa lmito leoylphosphat idy lchol ine (DPolPC) ,
dil inoleoylphosphatidylcholine (DLolPC), cardiolipin (heart,
bovine) (CL) and the lipophilic ﬂuorescent probe lissamine rhoda-
mine phosphatidylethanolamine (Rho-PE) were supplied by Avanti
Polar Lipids (Alabaster, AL, USA). Egg phosphatidylcholine (PC),
egg phosphatidylethanolamine (PE) egg phosphatidylglycerol (PG)
liver phosphatidylinositol (PI) and spinal cord phosphatidylserine
(PS) were purchased from Lipid Products (South Nutﬁed, UK). 8-
Aminonaphtalene-1,3,6-trisulfonic acid sodium salt (ANTS) and p-
xylenebis(pyridinium) bromide (DPX) were supplied by Molecular
Probes, Inc. (Eugene, OR). Trypsin-coated agarose beads, isopropyl
beta-D-thiogalactopyranoside (IPTG) and propidium iodide were sup-
plied by Sigma-Aldrich (Madrid, Spain). Hoechst 33342 was purchased
from Life-Technologies (Carlsbad, CA, USA). A ganglioside natural mix-
ture composed of GM1, GD1a, GD1Tb and GD1b (GS) was supplied by
Bachem (Heidelberg, Germany). Glutathione Sepharose 4B was sup-
plied by GE Healthcare (Little Chalfont, UK). Protease inhibitors were
purchased from Hoffmann-La Roche (Basel, Switzerland).
2.2. Methods
2.2.1. Epsilon-toxin expression and puriﬁcation
Epsilon-protoxin (EPTX) and epsilon-protoxin-GFP (EPTX-GFP)
were produced and puriﬁed as recombinant fusion proteins consisting
of GST-EPTX and GST-EPTX-GFP in a pGEX 4T1 expression vector. The
plasmids were kindly provided by J. Blasi (Barcelona, Spain). The puriﬁ-
cation of the toxins was performed following a published protocol [13].
Brieﬂy, either EPTX or EPTX-GFP were induced overnight with 0.4 mM
isopropyl beta-D-thiogalactopyranoside (IPTG) at room temperature in
250 ml LB medium culture supplemented with ampicillin. Cells were
pelleted and resuspended in cold PBS (supplemented with protease
inhibitors), frozen in liquid nitrogen, thawed and sonicated. Then the
homogenate was centrifuged at 15,000g for 20 min. The obtained
supernatant was incubated with 0.75 ml glutathione Sepharose 4B for
2 h at 4 °C. After two washes with PBS, the recombinant proteins were
eluted by thrombin cleavage in PBS containing 2.5 mM CaCl2. When re-
quired, EPTX and EPTX-GFP were cut and activated incubating with
trypsin-coated agarose beads for 1 h at room temperature.
2.2.2. Large unilamellar vesicle (LUV) preparation and permeabilization
assay
Vesicle efﬂuxwasmeasured with the ANTS:DPX system [14] using a
described method [15,16]. Brieﬂy, the desired amounts of lipid stocks
dissolved in chloroform:methanol solution (2:1 v/v) were mixed in
the required proportions, and the solvent was evaporated to drynessunder a stream of nitrogen. Traces of solvent were removed by leaving
the samples under high vacuum for at least 2 h. The samples were
hydrated in 12.5 mM ANTS, 45 mM DPX, 75 mM NaCl and 2.5 mM
HEPES, pH 7.4. LUV (100 nmdiameter)were prepared following the ex-
trusionmethod [17]. The vesicles were extruded using Nuclepore ﬁlters
(0.1 μm pore diameter), at a temperature above the transition temper-
ature of the lipid mixtures, and the vesicle suspension was passed
through a PD-10 desalting column to remove non-entrapped ANTS
and DPX. A previously adjusted isosmotic buffer solution was used for
this process (75mMNaCl, 2.5mMHEPES, pH 7.4), and the lipid concen-
tration was measured in terms of lipid phosphorous [18]. ETX was
added to 0.05 mM vesicles in a stirred quartz cuvette, and leakage was
followed in terms of ANTS ﬂuorescence in a Microbeam PTI spectroﬂu-
orimeter (Barcelona, Spain) using a cutoff ﬁlter (470 nm) placed be-
tween the sample and the emission monochromator and setting the
ANTS emission at 520 nm and the excitation at 355 nm. The percentage
leakage induced by the membrane-perturbing agent was calculated by
the equation Leakage (%) = (Fi – F0) / (Fmax – F0) × 100, where F0 is
baseline leakage and corresponds to the ﬂuorescence of the vesicles at
time 0, Fi is the ﬂuorescence after a certain period of incubation with
the peptide and Fmax is the maximum leakage that corresponds to the
ﬂuorescence value obtained after addition of Triton X-100.2.2.3. Cell culture
Madin–Darby canine kidney epithelial cells (MDCK) were grown at
37 °C with 5% CO2 in Dulbecco's modiﬁed Eagle's medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) and penicillin-
streptomycin-glutamine.
2.2.4. Measurement of apoptotic and necrotic nuclei
Cell nuclei were stained with Hoechst 33342 or propidium iodide
(PrI) to distinguish between apoptotic and necrotic nuclei by
epiﬂuorescence microscopy. This assay was performed as described
[19]. Brieﬂy, after treatment with ETX, MDCK cells were incubated
15 min with 1 μM Hoechst and 1.5 μM propidium iodide (PrI). The
plate was next moved to an epiﬂuorescence microscope to obtain
images of stained nuclei. To differentiate apoptotic fromnormal and ne-
crotic nuclei, the images were treated using Image J software (National
Institutes of Health, Bethesda, MD, USA).
2.2.5. Flow cytometry
Cell viability was assayed using ﬂow cytometry as described [20]
with somemodiﬁcations.MDCK cellswere incubatedwith ETX at differ-
ent concentrations. After toxin treatment cells were detached with 1×
citric saline buffer (135 mM KCl, 15 mM sodium citrate, pH 7.3) or
0.25% trypsin-EDTA, centrifuged at 2,000g for 5 min and washed twice
in PBS. Finally 0.5 μM propidium iodide was added, and cells were ana-
lyzed with a BD Facscalibur Cell Quest ﬂow cytometer (BD, Franklin
Lakes, NJ U.S.). The data were treated using the WinMDI 2.9 free
software.
2.2.6. Lipid extraction from MDCK cells
MDCK cells were grown to conﬂuency in 10,175 cc ﬂasks. Cells were
detachedwith amanual cell scraper and centrifuged at 1,500 rpm5min.
The pellet was diluted with 10 volumes of hypo-osmotic lysis buffer
(1.2 mM acetic acid, 4 mM MgSO4, pH 3.2) and incubated for 15 min
in ice with stirring. Lysed cells were centrifuged at 31,000g for 15 min
at 4 °C and washed twice with the same buffer. Lipids were extracted
adding 250 μl of 0.6 M perchloric acid to the same volume of pelleted
cells and centrifuging at 14,000g for 15min. The obtained pellet was re-
suspended in 2.5 ml cold chloroform/methanol (2:1, [v:v]) and incubat-
ed for 30min at room temperaturewith stirring. In the next step, 5ml of
cold 0.1 N HCl was added, and after mixing, the sample was centrifuged
at 1,700g for 20 min. Two phases were so obtained, an upper phase
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Fig. 1. Confocal images of GUV composed of (A,B) DOPC and (C,D) DOPC:SM:Ch 2:1:1, incubated with different concentrations of ETX-GFP. Bar: 10 μm.
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phase”) that was collected.
2.2.7. GUV preparation
Giant unilamellar vesicles (GUV) were prepared using a published
method [21]. Brieﬂy, pure lipid stocks were prepared by diluting com-
mercially available lipids in powder into a chloroform/methanol
(2:1 v/v) organic solution to a 0. 2 mM concentration with 0.3 mol%
Rho-PE. From this solution, 5 μl was spread onto two platinum-wire
electrodes attached to a specially designed polytetraﬂuoroethyl
(PFTE)-made circular wells, and solvent traces were removed in a
high vacuum desiccator for 2 h. Then the circular wells were ﬁtted
into speciﬁc holes within a specially designed home-made chamber.
The platinum wires were attached in direct contact with a glass cover
slide with epoxy glue. The chamber was equilibrated for 15 min to the
desired temperature (above the Tm of all lipids) using an incorporated
water bath. The Pt-wires were covered with a GUV formation buffer
(2.5 mMHEPES, 75 mMNaCl, pH 7.4), and the chamber was connected
to a generator through the platinum electrodes following an electric
ﬁeld cycle: 6 min 0.22 V, 20 min 1.9 V and 90 min 5.3 V. At the end of
the cycle, the electric ﬁeld and water were both disconnected, and ves-
icles were left to equilibrate for 30min. Finally, the chamberwasmoved
to an inverted confocal ﬂuorescence microscope (Nikon D-ECLIPSE C1,
Nikon Inc., Melville, NY, USA) to visualize the vesicles attached to the
platinum wire. Image treatment and quantiﬁcation were performed
using the software EZ-C1 3.20 (Nikon, Tokyo, Japan).2.2.8. Formation of giant plasma membrane vesicles (GPMV)
GPMVwere formed by blebbing ofMDCK cells following a described
method [22] with same modiﬁcations. Brieﬂy, MDCK cells were grown
to conﬂuency and washed twice with GPMV buffer (2 mM CaCl2,
10 mM HEPES, 0.15 M NaCl, pH 7.4). Flasks were then incubated with
1.5 ml of freshly prepared GPMV reagent (25 mM formaldehyde and
2 mM DTT in GPMV buffer) for 1 h at 37 °C with stirring. After incuba-
tion, GPMV were gently decanted, centrifuged at 14,000 rpm in a
minispin and washed twice with GPMV buffer. They were then resus-
pended in 500 μl GPMV buffer and added to a μ-slide 8-well chamber
previously incubated with polylysine. Vesicles were let to lay down for
at least 3 h, and 2.5 μM Rho-PE was added to stain GPMV membranes.
After 15 min incubation, vesicles were visualized with an inverted
confocal ﬂuorescence microscope (Nikon D-ECLIPSE C1, Nikon Inc.,
Melville, NY, USA). Image treatment and quantiﬁcationwere performed
using the software EZ-C1 3.20 (Nikon Inc.).3. Results
3.1. ETX and pure lipids
The capacity of ETX to permeabilize lipid bilayers was tested with
LUV loaded with ANTS-DPX. PC, SM, Ch, ethyl PC, POPC, DOPC, DPolPC,
DLolPC, CL, PE, PG, PS, PI, PiP and GSwere used either alone or in various
combinations to assay vesicle leakage induced by ETX. The results were
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Fig. 2. Confocal images of (A,B) GUV composed of MDCK cells lipid extract and (C,D) GPMV formed by blebbing of MDCK cells, incubated with different concentrations of ETX-GFP. Bar:
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(results not shown). Only when the bilayers consisted of pure DOPC
some release of aqueous contents (approx. 15% in 30min)was detected.3.2. Binding of ETX-GFP to GUV and GPMV membranes
Giant unilamellar vesicles (GUV) were formed to check the ability of
ETX to interact with unilamellar lipidic vesicles visible with a confocal
microscope, using Rho-PE to stain them and to differentiate liquid-
ordered from disordered domains. To visualize the toxin, an ETX tagged
with GFP was used (ETX-GFP). Since in the LUV studies only DOPC
allowed some leakage, GUV of DOPC were formed. Moreover, to evalu-
ate the inﬂuence of liquid-ordered domains on the activity of ETX, GUV
composed of a ternary mixture of DOPC:SM:Ch (2:1:1 mol ratios) were
also formed. This mixture was checked because of the results described
in the literature that suggest localization of ETX in “raft” domains of
MDCK [10]. No binding of ETX-GFP was detected to GUV of either
pure DOPC or a DOPC:SM:Ch ternary mixture (Fig. 1).
To exclude a possible implication of some speciﬁc lipid, found in the
toxin-sensitive cells, GUV composed of a lipid extract of MDCK cells
were formed.Moreover, to evaluate the implication of a possible protein
receptor GPMV obtained by blebbing of MDCK cells were formed. The
basic difference between these two types of vesicles is probably in
their protein content.ETX-GFP did not bind membranes of GUV composed of the MDCK
cells lipid extract (Fig.2A, B), conﬁrming the inability of ETX-GFP to in-
sert in bilayers composed of pure lipid. However, ETX-GFP did bind
GPMV, i.e., giant vesicles consisting of MDCK plasma membranes ob-
tained by blebbing. Moreover, in some vesicles the ETX-GFP appeared
to have internalized through GPMV membrane (Fig 2C, D).
3.3. Treatment of MDCK cells with ETX-GFP
The plasma membrane of MDCK cells was stained with Rho-PE, to
establish whether ETX-GFP co-localized with the cell membrane. The
results shown in Fig. 3 indicate that ETX-GFP co-localized with plasma
membrane at 70 nM already after 2 min incubation. Moreover, cells
showed a vacuolization process after 5min incubation and an extended
necrosis after 15 min.
ETX-GFP caused MDCK permeabilization, allowing the entrance of
PrI, conﬁrming the necrotic effects checked for ETX by cell counting
(Fig. 4). Also, the entrance of ETX-GFP was visible in both images after
10 min incubation.
3.3.1. Measurement of apoptotic and necrotic nuclei
The ability of ETX to cause cell death was checked inMDCK at differ-
ent times and concentrations. This assay allows differentiating between
apoptosis and necrosis using a morphologic approach. PrI is a nucleic
acid stain used to count cells in multicolor ﬂuorescent techniques.
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Fig. 3. Transmitted light and confocal images of MDCK cells treated with 70 nM ETX-GFP and stained with Rho-PE to stain plasma membrane.
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20- to 30-fold. Since PrI is membrane impermeant to viable cells, it is
used to detect necrotic cells in culture [23]. However, cells in advanced
states of apoptosis undergo morphological changes, especially in nuclei
as chromatin condensation (pyknosis) and, at later stages, nuclei frag-
mentation (karyorrhexis). Pyknotic and fragmented nuclei were count-
ed staining cell nuclei with Hoechst 33342 [24].
Fig. 5 shows that ETX has caused necrotic effectswith time and dose-
dependence.Moreover, no clear increase in apoptotic nuclei was detect-
ed with concentration or time. ETX has also shown the ability to kill
MDCK cells at concentrations in the nanomolar order conﬁrming it to
be one of the most potent bacterial toxins described in the literature
[3].
ETX does not exhibit any toxic activity in other cell lines checked,
such as epithelial cells (HeLa human cervix adenocarcinoma cells)
intestinal cells (CaCo2 colorectal adenocarcinoma cells), MEF (mouse
embryonic ﬁbroblasts) or GM95 (mouse melanoma cells).3.3.2. Cell viability of MDCK cells treated with trypsin and citric buffer
Flow cytometry was performed to evaluate cell viability of MDCK
cells detachedwith either citric buffer and trypsin. It is known that tryp-
sin hydrolizes a certain number of cell surface proteins and plasma
membrane receptors that allow cell adhesion. Indeed trypsin is com-
monly used to detach cells grown on ﬂasks and plates [25]. This exper-
iment allows us to evaluate the ability of ETX to kill cells treated with
citric buffer and cells treated with trypsin, that have possibly been
deprived of the putative cell receptor necessary for ETX cytotoxicity.Flow cytometry results obtained withMDCK cells treated with citric
buffer showed an increase of necrosis from ~25% to ~70% when treated
with 8 nMETXandno signiﬁcant effect at 2 nM(Fig. 6). However,MDCK
cells treated with trypsin did not show a signiﬁcant increase in necrosis
when treated with 2 or 8 nM ETX. Moreover, an increase of basal cell
death in cells detached with citric buffer was observed (Fig. 6).4. Discussion
GFP-tagged ETX had shown no insertion in GUV bilayers composed
of DOPC or of the DOPC:SM:Ch (2:1:1) ternary mixture at the different
concentrations checked; however, the toxin did localized on the
MDCK cell surface and caused cytotoxicity. Themost interesting conclu-
sion of thiswork could be derived from the inability of the toxin to insert
in GUV composed of a lipid extract from MDCK cells, and the co-
localization in GPMV formed from MDCK cells plasma membranes
(Fig. 2). The differences between these vesicles are perhaps only in pro-
tein content. GPMV havemaintainedmembrane proteins and perhaps a
putative receptor that could be necessary for binding of ETX to plasma
membrane cells, toxin oligomerization and ﬁnally pore formation.
These results are reinforced by the toxin co-localization with MDCK
plasmamembrane stained with Rho-PE in cells (Fig. 3). Also in support
of the receptor theory is the higher cytotoxicity obtained for MDCK de-
tachedwith citric buffer than with trypsin. For this experimentwe have
used two different approaches to detach cells. In the ﬁrst case, we have
used citric buffer, commonly used in ﬂow cytometry protocols [26,27].
This buffer allows to detach cells without proteases and it ensures the
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cell biology to detach cells taking advantage of its ability to cleave the
proteins binding the cultured cells to the dish [25]; moreover, it could
also cleave proteins on the cell surface, including putative receptors
[26]. In our results, the cell population detached with trypsin have
shown no signiﬁcant differences in cytotoxicity when treated with
ETX at 2 and 8 nM with respect to the negative control. However, cells
treated with citric buffer have shown an increase from ~25% to ~70%
when treated with 8 nM ETX. The difference could be due to the pres-
ence of a cell receptor in citrate-treated cells that is cutoff by trypsin
treatment. Note, however, that cells treated with citric buffer have
shown a higher basal death, indicating a toxicity of this reagent to
MDCK cells. These results are in agreement with the speciﬁcity of ETX
for MDCK cells, previously described [28]. ETX has shown no activity
in several cell lines different from MDCK cells, among them epithelial
and intestinal cells that are known to be infected and killed by ETX
in vivo [6] (data not shown).
Cell counting assays have allowed a general characterization of the
cell death caused by ETX. The results show that the toxin caused a fast
and extended necrosis at very low concentrationswith no signiﬁcant in-
crease in apoptotic nuclei (pyknotic nuclei and karyorrhexis). ETX is
known to be a pore-forming protein with structural similarity with
aerolysin from Aeromonas hydrophila. Aerolysin induces leakage of 6-
carboxyﬂuorescein (CF) in LUV [29]; however, in unpublished results,
ETX has shown no activity in LUV not even in the presence of charged
lipids, which are described in the literature to increase the perme-
abilization of vesicles after treatment with several other proteins
[29–32]. Note in particular that aerolysin [29] can permeabilizepure lipid bilayers. Moreover, the presence of a liquid-ordered phase
seems not to have any effect on ETX activity in vesicles, although the
localization of ETX in “raft” domains has been described in the literature
[10].
Also relevant in this contest is the increase in permeability for both
GPMV and MDCK cells treated with ETX-GFP, allowing toxin internali-
zation. In GPMV images, we can see an increase in green signal in the
inner area of some vesicles (Fig. 2D). Moreover, using PrI (Fig. 4), we
have seen that the internalization of this dye happened simultaneously
with the internalization of ETX-GFP. These observations support the
idea that the toxin enters through anunspeciﬁc increase in permeability
rather than through a regulated transport system. This increase in per-
meability is preceded by a localization of ETX-GFP on the cell surface
and could be a result of an advanced phase of cytotoxicity including for-
mation of large pores.
The requirement of a receptor protein on the target cell surface for
bacterial toxins to exert their lytic role is not exceptional. It has been
found for Escherichia coli alpha-hemolysin [33], Vac A toxin from
Helicobacter pylori [34] and Staphylococcus aureus pore-forming toxins
[35], among others. The nature of the receptor is not always known.
E. coli alpha-hemolysin binds glycophorin to lyse red blood cells [33],
and H. pylori Vac A binds receptor tyrosine phosphatase beta leading
to cytoplasmic vacuolization of gastric epithelial cells [34]. No structural
or functional pattern arises from the few examples of bacterial toxin re-
ceptors known. In the case of the proposed ETX receptor, little can be
said, beyond the fact that it appears to be a trypsin-sensitive protein.
A possible candidate identiﬁed by Ivie et al. [36] is the hepatitis A
virus cellular receptor 1 (HAVCR1), which could contribute to the
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Fig. 5. Apoptotic and necrotic nuclei of MDCK cells treated with ETX (0.8 to 8 nM) after
30 min, 1 h and 4 h incubation.
Fig. 6. Flow cytometry assay performed using propidium iodide (PrI) to stain necrotic cells
was used to check the viability of MDCK cells treated with either citric buffer or trypsin.
803M.M. Manni et al. / Biochimica et Biophysica Acta 1848 (2015) 797–804cytotoxicity of the protein acting as a receptor or co-receptor in MDCK
cells and the human kidney cell line ACHN.
In conclusion, the present study supports, with model membrane
and cell biology studies, that ETX requires a cell receptor, probably a
protein to bind plasma membrane and cause cell death. Moreover, the
toxin causes necrosis accompanied by a vacuolization process. Also,
ETX causes permeabilization in GMPV and MDCK cells.
Acknowledgments
The authors are greatful to Dr. J. Blasi (University of Barcelona) for
the gift of epsilon-protoxin and epsilon-protoxin-GFP plasmids and to
Dr. A. Alape-Girón and Dr. M. Florez-Dìaz (University of Costa Rica) for
suggesting an investigation on epsilon-toxin and for providing some
lipids used in preliminary assays. This work was supported in part by
BFU 2012-36241, from the Spanish Ministry of Economy, and by grant
IT 849-13 from the Basque government.M.M.was a predoctoral student
supported by the Basque government.
References
[1] J.G. Songer, Clostridial enteric diseases of domestic animals, Clin. Microbiol. Rev. 9
(1996) 216.
[2] M. Nagahama, Y. Okagawa, T. Nakayama, E. Nishioka, J. Sakurai, Site-directed muta-
genesis of histidine residues in Clostridium perfringens alpha-toxin, J. Bacteriol. 177
(1995) 1179–1185.
[3] N.J. Mantis, Vaccines against the category B toxins: Staphylococcal enterotoxin B,
epsilon toxin and ricin, Adv. Drug Deliv. Rev. 57 (2005) 1424–1439.
[4] D. Chandran, S.S. Naidu, P. Sugumar, G.S. Rani, S.P. Vijayan, D. Mathur, L.C. Garg, V.A.
Srinivasan, Development of a recombinant epsilon toxoid vaccine against
enterotoxemia and its use as a combination vaccine with live attenuated sheep
pox virus against enterotoxemia and sheep pox, Clin. Vaccine Immunol. 17 (2010)
1013–1016.
[5] O. Knapp, B. Stiles, M.R. Popoff, The aerolysin-like toxin family of cytolytic, pore-
forming toxins, Open Toxinol. J. 3 (2010) 53–68.
[6] M. Bokori‐Brown, C.G. Savva, S.P. Fernandes da Costa, C.E. Naylor, A.K. Basak, R.W.
Titball, Molecular basis of toxicity of Clostridium perfringens epsilon toxin, FEBS J.
278 (2011) 4589–4601.
[7] M. Nagahama, H. Hara, M. Fernandez-Miyakawa, Y. Itohayashi, J. Sakurai, Oligomer-
ization of Clostridium perfringens epsilon-toxin is dependent upon membrane ﬂuid-
ity in liposomes, Biochemistry 45 (2006) 296–302.
[8] L. Petit, E. Maier, M. Gibert, M.R. Popoff, R. Benz, Clostridium perfringens epsilon toxin
induces a rapid change of cell membrane permeability to ions and forms channels in
artiﬁcial lipid bilayers, J. Biol. Chem. 276 (2001) 15736–15740.
804 M.M. Manni et al. / Biochimica et Biophysica Acta 1848 (2015) 797–804[9] D.W. Payne, E.D. Williamson, H. Havard, N. Modi, J. Brown, Evaluation of a new cy-
totoxicity assay for Clostridium perfringens type D epsilon toxin, FEMS Microbiol.
Lett. 116 (1994) 161–167.
[10] S. Miyata, J. Minami, E. Tamai, O. Matsushita, S. Shimamoto, A. Okabe, Clostridium
perfringens epsilon-toxin forms a heptameric pore within the detergent-insoluble
microdomains of Madin–Darby canine kidney cells and rat synaptosomes, J. Biol.
Chem. 277 (2002) 39463–39468.
[11] M. Nagahama, Y. Itohayashi, H. Hara,M. Higashihara, Y. Fukatani, T. Takagishi,M.Oda,
K. Kobayashi, I. Nakagawa, J. Sakurai, Cellular vacuolation induced by Clostridium
perfringens epsilon-toxin, FEBS J. 278 (2011) 3395–3407.
[12] L. Petit, M. Gibert, D. Gillet, C. Laurent-Winter, P. Boquet, M.R. Popoff, Clostridium
perfringens epsilon-toxin acts onMDCK cells by forming a largemembrane complex,
J. Bacteriol. 179 (1997) 6480–6487.
[13] A. Soler-Jover, J. Dorca, M.R. Popoff, M. Gibert, J. Saura, J.M. Tusell, J. Serratosa, J. Blasi,
M. Martin-Satue, Distribution of Clostridium perfringens epsilon toxin in the brains of
acutely intoxicated mice and its effect upon glial cells, Toxicon 50 (2007) 530–540.
[14] H. Ellens, J. Bentz, F.C. Szoka, H+- and Ca2+-induced fusion and destabilization of
liposomes, Biochemistry 24 (1985) 3099–3106.
[15] F.M. Goñi, J.L. Nieva, G. Basanez, G. Fidelio, A. Alonso, Phospholipase-C-promoted
liposome fusion, Biochem. Soc. Trans. 22 (1994) 839–844.
[16] J.L. Nieva, F.M. Goñi, A. Alonso, Liposome fusion catalytically induced by phospholi-
pase C, Biochemistry 28 (1989) 7364–7367.
[17] L. Mayer, M. Hope, P. Cullis, Vesicles of variable sizes produced by a rapid extrusion
procedure, Biochim. Biophys. Acta 858 (1986) 161–168.
[18] A.D. Bangham, M.M. Standish, J.C. Watkins, Diffusion of univalent ions across the
lamellae of swollen phospholipids, J. Mol. Biol. 13 (1965) 238–252.
[19] C. Dive, C.D. Gregory, D.J. Phipps, D.L. Evans, A.E. Milner, A.H. Wyllie, Analysis and
discrimination of necrosis and apoptosis (programmed cell death) by multiparam-
eter ﬂow cytometry, Biochim. Biophys. Acta 1133 (1992) 275–285.
[20] M. Al-Rubeai, K. Welzenbach, D. Lloyd, A. Emery, A rapid method for evaluation of
cell number and viability by ﬂow cytometry, Cytotechnology 24 (1997) 161–168.
[21] L. Montes, A. Alonso, F.M. Goñi, L.A. Bagatolli, Giant unilamellar vesicles
electroformed from native membranes and organic lipid mixtures under physiolog-
ical conditions, Biophys. J. 93 (2007) 3548–3554.
[22] T. Baumgart, A.T. Hammond, P. Sengupta, S.T. Hess, D.A. Holowka, B.A. Baird, W.W.
Webb, Large-scale ﬂuid/ﬂuid phase separation of proteins and lipids in giant plasma
membrane vesicles, Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 3165–3170.
[23] I.U. Cevik, T. Dalkara, Intravenously administered propidium iodide labels necrotic
cells in the intact mouse brain after injury, Cell Death Differ. 10 (2003) 928–929.[24] S. Allen, J. Sotos, M. Sylte, C. Czuprynski, Use of Hoechst 33342 staining to detect
apoptotic changes in bovine mononuclear phagocytes infected withMycobacterium
avium subsp. paratuberculosis, Clin. Diagn. Lab. Immunol. 8 (2001) 460–464.
[25] H.L. Huang, H.W. Hsing, T.C. Lai, Y.W. Chen, T.R. Lee, H.T. Chan, P.C. Lyu, C.L. Wu, Y.C.
Lu, S.T. Lin, Research trypsin-induced proteome alteration during cell subculture in
mammalian cells, J. Biomed. Sci. 17 (2010) 36.
[26] B. Zhang, H. Shan, D. Li, Z. Li, K. Zhu, Z. Jiang, M. Huang, Different methods of
detaching adherent cells signiﬁcantly affect the detection of TRAIL receptors,
Tumori 98 (2012) 800–803.
[27] Y. Nie, P. Walsh, D.L. Clarke, J.A. Rowley, T. Fellner, Scalable passaging of adherent
human pluripotent stem cells, PLoS One 9 (2014) e88012.
[28] M.R. Popoff, Epsilon toxin: a fascinating pore-forming toxin, FEBS J. 278 (2011)
4602–4615.
[29] A. Alonso, F.M. Goñi, J.T. Buckley, Lipids favoring inverted phase enhance the ability
of aerolysin to permeabilize liposome bilayers, Biochemistry 39 (2000)
14019–14024.
[30] C.A. Valcarcel, M. Dalla Serra, C. Potrich, I. Bernhart, M. Tejuca, D. Martinez, F. Pazos,
M.E. Lanio, G. Menestrina, Effects of lipid composition on membrane perme-
abilization by sticholysin I and II, two cytolysins of the sea anemone Stichodactyla
helianthus, Biophys. J. 80 (2001) 2761–2774.
[31] A.N. Stefanovic, M.T. Stöckl, M.M. Claessens, V. Subramaniam, α-Synuclein
oligomers distinctively permeabilize complex model membranes, FEBS J. 281
(2014) 2838–2850.
[32] B.A. Costa, L. Sanches, A. Gomide, F. Bizerra, C. Dal Mas, E.B. Oliveira, K.R. Perez, R.
Itri, N. Oguiura, M.A. Hayashi, Interaction of the rattlesnake toxin crotamine with
model membranes, J. Phys. Chem. B 5471–5479 (2014).
[33] A.L. Cortajarena, F.M. Goñi, H. Ostolaza, Glycophorin as a receptor for Escherichia coli
alpha-haemolysin in erythrocytes, J. Biol. Chem. 276 (2001) 12513–12519.
[34] T. Kimura, A. Wada, M. Nakayama, K. Ogushi, Y. Nishi, B.B. De Guzman, J. Moss, T.
Hirayama, High molecular weight factor in FCS inhibits Helicobacter pylori Vac A-
binding to its receptor, RPTPbeta, on AZ-521, Microbiol. Immunol. 47 (2003)
105–107.
[35] A.L. Dumont, V.J. Torres, Cell targeting in the Staphylococcus aureus pore-forming
toxins: it's not just about lipids, Trends Microbiol. 22 (2014) 21–27.
[36] S.E. Ivie, C.M. Fennessey, J. Sheng, D.H. Rubin, Gene-trap mutagenesis identiﬁes
mammalian genes contributing to intoxication by Clostridium perfringens epsilon-
toxin, PLoS One 6 (2011) e17787.
